Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 204

1.

The European Network for ICU-Related Respiratory Infections (ENIRRIs) ERS Clinical Research Collaboration.

Martin-Loeches I, Torres A; ENIRRIs Clinical Research Collaboration.

Eur Respir J. 2019 Jan 3;53(1). pii: 1801972. doi: 10.1183/13993003.01972-2018. Print 2019 Jan. No abstract available.

PMID:
30606764
2.

Comparing current US and European guidelines for nosocomial pneumonia.

Kelly DN, Martin-Loeches I.

Curr Opin Pulm Med. 2018 Dec 28. doi: 10.1097/MCP.0000000000000559. [Epub ahead of print]

PMID:
30601179
3.

Transcriptomic depression of immunological synapse as a signature of ventilator-associated pneumonia.

Almansa R, Nogales L, Martín-Fernández M, Batlle M, Villareal E, Rico L, Ortega A, López-Campos G, Andaluz-Ojeda D, Ramírez P, Socias L, Tamayo L, Vallés J, Bermejo-Martín JF, Martín-Loeches I.

Ann Transl Med. 2018 Nov;6(21):415. doi: 10.21037/atm.2018.05.12.

4.

Hot topics in ventilator-associated pneumonia.

Nseir S, Martin-Loeches I.

Ann Transl Med. 2018 Nov;6(21):414. doi: 10.21037/atm.2018.11.09. No abstract available.

5.

Choice of fluids in critically ill patients.

Martin C, Cortegiani A, Gregoretti C, Martin-Loeches I, Ichai C, Leone M, Marx G, Einav S.

BMC Anesthesiol. 2018 Dec 22;18(1):200. doi: 10.1186/s12871-018-0669-3. Review.

6.

Improved Endotracheal Tubes for Prevention of Ventilator-Associated Pneumonia: Better Than Silver and Gold?

Rouzé A, Martin-Loeches I, Nseir S.

Respir Care. 2019 Jan;64(1):108-109. doi: 10.4187/respcare.06698. No abstract available.

PMID:
30578362
7.

Efficacy and safety of antimicrobial de-escalation as a clinical strategy.

Mathieu C, Pastene B, Cassir N, Martin-Loeches I, Leone M.

Expert Rev Anti Infect Ther. 2018 Dec 20. doi: 10.1080/14787210.2019.1561275. [Epub ahead of print]

PMID:
30570361
8.

Sepsis in Intensive Care Unit Patients: Worldwide Data From the Intensive Care over Nations Audit.

Sakr Y, Jaschinski U, Wittebole X, Szakmany T, Lipman J, Ñamendys-Silva SA, Martin-Loeches I, Leone M, Lupu MN, Vincent JL; ICON Investigators.

Open Forum Infect Dis. 2018 Nov 19;5(12):ofy313. doi: 10.1093/ofid/ofy313. eCollection 2018 Dec.

9.

Surgical antimicrobial prophylaxis in intensive care unit (ICU) patients: a preliminary, observational, retrospective study.

Duclos G, Pastene B, Depeyre F, Meresse Z, Cassir N, Martin-Loeches I, Einav S, Zieleskiewicz L, Leone M.

Ann Transl Med. 2018 Oct;6(20):402. doi: 10.21037/atm.2018.09.56.

10.

Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients with Community-Acquired Pneumonia.

Ceccato A, Cilloniz C, Martin-Loeches I, Ranzani OT, Gabarrus A, Bueno L, Garcia-Vidal C, Ferrer M, Niederman MS, Torres A.

Chest. 2018 Nov 22. pii: S0012-3692(18)32733-8. doi: 10.1016/j.chest.2018.11.006. [Epub ahead of print]

PMID:
30471269
11.

Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units.Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.

Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arıkan Akdagli S, Azoulay E, Blot S, Cornely O, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T; From the Study Group for Infections in Critically Ill Patients (ESGCIP) and the Fungal Infection Study Group (EFISG) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the European Society of Intensive Care Medicine (ESICM), the European Confederation of Medical Mycology (ECMM), and the Mycoses Study Group Education and Research Consortium (MSGERC).

Mycoses. 2018 Nov 13. doi: 10.1111/myc.12869. [Epub ahead of print]

PMID:
30426598
12.

Future of the ICU: finding treatable needles in the data haystack.

Bos LDJ, Azoulay E, Martin-Loeches I.

Intensive Care Med. 2018 Nov 12. doi: 10.1007/s00134-018-5454-8. [Epub ahead of print] No abstract available.

PMID:
30421255
13.

Influenza A: New Therapeutic Targets for a Deadly Disease.

Manzano D, Izquierdo-Garcia JL, Martín-Loeches I, Lorente JA.

Arch Bronconeumol. 2018 Nov 5. pii: S0300-2896(18)30354-5. doi: 10.1016/j.arbres.2018.09.020. [Epub ahead of print] English, Spanish. No abstract available.

14.

How Can We Distinguish Ventilator-Associated Tracheobronchitis from Pneumonia?

Keane S, Vallecoccia MS, Nseir S, Martin-Loeches I.

Clin Chest Med. 2018 Dec;39(4):785-796. doi: 10.1016/j.ccm.2018.08.003. Review.

PMID:
30390749
15.

Airway Devices in Ventilator-Associated Pneumonia Pathogenesis and Prevention.

Rouzé A, Martin-Loeches I, Nseir S.

Clin Chest Med. 2018 Dec;39(4):775-783. doi: 10.1016/j.ccm.2018.08.001. Review.

PMID:
30390748
16.

Optimal duration of antibiotic treatment in Gram-negative infections.

De Waele JJ, Martin-Loeches I.

Curr Opin Infect Dis. 2018 Dec;31(6):606-611. doi: 10.1097/QCO.0000000000000491.

PMID:
30382951
17.

Steroids and severe pneumonia. Ready for the winter? Discussion on "Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study".

De Pascale G, Bello G, Dell'Anna AM, Montini L, Antonelli M, Moreno G, Rodriguez A, Martin-Loeches I.

Intensive Care Med. 2018 Dec;44(12):2319-2320. doi: 10.1007/s00134-018-5414-3. Epub 2018 Oct 24. No abstract available.

PMID:
30357443
18.

Appraisal of systemic inflammation and diagnostic markers in a porcine model of VAP: secondary analysis from a study on novel preventive strategies.

Li Bassi G, Prats RG, Artigas A, Xiol EA, Marti JD, Ranzani OT, Rigol M, Fernandez L, Meli A, Battaglini D, Luque N, Ferrer M, Martin-Loeches I, Póvoa P, Chiumello D, Pelosi P, Torres A.

Intensive Care Med Exp. 2018 Oct 20;6(1):42. doi: 10.1186/s40635-018-0206-1.

19.

Beat around the bush for VA-LRTI.

Martin-Loeches I, Depuydt P, Niederman MS.

Intensive Care Med. 2018 Nov;44(11):1961-1963. doi: 10.1007/s00134-018-5281-y. Epub 2018 Oct 21. No abstract available.

PMID:
30343316
20.

C-reactive protein and procalcitonin profile in ventilator-associated lower respiratory infections.

Coelho L, Rabello L, Salluh J, Martin-Loeches I, Rodriguez A, Nseir S, Gomes JA, Povoa P; TAVeM study Group.

J Crit Care. 2018 Dec;48:385-389. doi: 10.1016/j.jcrc.2018.09.036. Epub 2018 Oct 2.

PMID:
30308469
21.

Systematic review on the first line treatment of amphotericin B in critically ill adults with candidemia or invasive candidiasis.

Keane S, Geoghegan P, Povoa P, Nseir S, Rodriguez A, Martin-Loeches I.

Expert Rev Anti Infect Ther. 2018 Nov;16(11):839-847. doi: 10.1080/14787210.2018.1528872. Epub 2018 Oct 4.

PMID:
30257597
22.

Clinical characteristics, evolution, and treatment-related risk factors for mortality among immunosuppressed patients with influenza A (H1N1) virus admitted to the intensive care unit.

Garnacho-Montero J, León-Moya C, Gutiérrez-Pizarraya A, Arenzana-Seisdedos A, Vidaur L, Guerrero JE, Gordón M, Martín-Loeches I, Rodriguez A; on Behalf GETGAG Study Group.

J Crit Care. 2018 Dec;48:172-177. doi: 10.1016/j.jcrc.2018.08.017. Epub 2018 Aug 24.

PMID:
30216935
23.

Change is in the air: dying to breathe oxygen in acute respiratory distress syndrome?

Geoghegan P, Keane S, Martin-Loeches I.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2133-S2137. doi: 10.21037/jtd.2018.06.73. No abstract available.

24.

Severe community-acquired pneumonia: current management and future therapeutic alternatives.

Garnacho-Montero J, Barrero-García I, Gómez-Prieto MG, Martín-Loeches I.

Expert Rev Anti Infect Ther. 2018 Sep;16(9):667-677. doi: 10.1080/14787210.2018.1512403. Epub 2018 Sep 3.

PMID:
30118377
25.

Hemodynamic management of critically ill burn patients: an international survey.

Soussi S, Berger MM, Colpaert K, Dünser MW, Guttormsen AB, Juffermans NP, Knape P, Koksal G, Lavrentieva A, Leclerc T, Lorente JA, Martin-Loeches I, Metnitz P, Pantet O, Pelosi P, Rousseau AF, Sjöberg F, Legrand M; ESICM Burn ICU working group.

Crit Care. 2018 Aug 17;22(1):194. doi: 10.1186/s13054-018-2129-3. No abstract available.

26.

Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.

Moreno G, Rodríguez A, Reyes LF, Gomez J, Sole-Violan J, Díaz E, Bodí M, Trefler S, Guardiola J, Yébenes JC, Soriano A, Garnacho-Montero J, Socias L, Del Valle Ortíz M, Correig E, Marín-Corral J, Vallverdú-Vidal M, Restrepo MI, Torres A, Martín-Loeches I; GETGAG Study Group.

Intensive Care Med. 2018 Sep;44(9):1470-1482. doi: 10.1007/s00134-018-5332-4. Epub 2018 Aug 3.

PMID:
30074052
27.

New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.

Martin-Loeches I, Rodriguez AH, Torres A.

Curr Opin Crit Care. 2018 Oct;24(5):347-352. doi: 10.1097/MCC.0000000000000535.

PMID:
30063491
28.

Public awareness of sepsis is still poor: we need to do more.

Kerrigan SW, Martin-Loeches I.

Intensive Care Med. 2018 Oct;44(10):1771-1773. doi: 10.1007/s00134-018-5307-5. Epub 2018 Jul 19. No abstract available.

PMID:
30027308
29.

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia.

Cillóniz C, Liapikou A, Martin-Loeches I, García-Vidal C, Gabarrús A, Ceccato A, Magdaleno D, Mensa J, Marco F, Torres A.

PLoS One. 2018 Jul 18;13(7):e0200504. doi: 10.1371/journal.pone.0200504. eCollection 2018.

30.

Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia.

Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, François Timsit J, Welte T, Wunderink R.

ERJ Open Res. 2018 Jun 26;4(2). pii: 00028-2018. doi: 10.1183/23120541.00028-2018. eCollection 2018 Apr.

31.

Surviving sepsis campaign: research priorities for sepsis and septic shock.

Coopersmith CM, De Backer D, Deutschman CS, Ferrer R, Lat I, Machado FR, Martin GS, Martin-Loeches I, Nunnally ME, Antonelli M, Evans LE, Hellman J, Jog S, Kesecioglu J, Levy MM, Rhodes A.

Intensive Care Med. 2018 Sep;44(9):1400-1426. doi: 10.1007/s00134-018-5175-z. Epub 2018 Jul 3.

PMID:
29971592
32.

Surviving Sepsis Campaign: Research Priorities for Sepsis and Septic Shock.

Coopersmith CM, De Backer D, Deutschman CS, Ferrer R, Lat I, Machado FR, Martin GS, Martin-Loeches I, Nunnally ME, Antonelli M, Evans LE, Hellman J, Jog S, Kesecioglu J, Levy MM, Rhodes A.

Crit Care Med. 2018 Aug;46(8):1334-1356. doi: 10.1097/CCM.0000000000003225.

PMID:
29957716
33.

Current aspects in sepsis approach. Turning things around.

Candel FJ, Borges Sá M, Belda S, Bou G, Del Pozo JL, Estrada O, Ferrer R, González Del Castillo J, Julián-Jiménez A, Martín-Loeches I, Maseda E, Matesanz M, Ramírez P, Ramos JT, Rello J, Suberviola B, Suárez de la Rica A, Vidal P.

Rev Esp Quimioter. 2018 Aug;31(4):298-315. Epub 2018 Jun 25. Review.

34.

What's new in restoring the gut microbiota in ICU patients? Potential role of faecal microbiota transplantation.

Ruppé E, Martin-Loeches I, Rouzé A, Levast B, Ferry T, Timsit JF.

Clin Microbiol Infect. 2018 Aug;24(8):803-805. doi: 10.1016/j.cmi.2018.05.020. Epub 2018 Jun 2. No abstract available.

PMID:
29870851
35.

Feasibility of Antimicrobial Stewardship (AMS) in Critical Care Settings: A Multidisciplinary Approach Strategy.

Tiszai-Szucs T, Mac Sweeney C, Keaveny J, Bozza FA, O Hagan Z, Martin-Loeches I.

Med Sci (Basel). 2018 May 25;6(2). pii: E40. doi: 10.3390/medsci6020040.

36.

Lower Respiratory Tract Infection and Short-Term Outcome in Patients With Acute Respiratory Distress Syndrome.

Zampieri FG, Póvoa P, Salluh JI, Rodriguez A, Valade S, Andrade Gomes J, Reignier J, Molinos E, Almirall J, Boussekey N, Socias L, Ramirez P, Viana WN, Rouzé A, Nseir S, Martin-Loeches I; TAVeM study group.

J Intensive Care Med. 2018 Jan 1:885066618772498. doi: 10.1177/0885066618772498. [Epub ahead of print]

PMID:
29699468
37.

Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study).

Welte T, Dellinger RP, Ebelt H, Ferrer M, Opal SM, Singer M, Vincent JL, Werdan K, Martin-Loeches I, Almirall J, Artigas A, Ignacio Ayestarán J, Nuding S, Ferrer R, Sirgo Rodríguez G, Shankar-Hari M, Álvarez-Lerma F, Riessen R, Sirvent JM, Kluge S, Zacharowski K, Bonastre Mora J, Lapp H, Wöbker G, Achtzehn U, Brealey D, Kempa A, Sánchez García M, Brederlau J, Kochanek M, Reschreiter HP, Wise MP, Belohradsky BH, Bobenhausen I, Dälken B, Dubovy P, Langohr P, Mayer M, Schüttrumpf J, Wartenberg-Demand A, Wippermann U, Wolf D, Torres A.

Intensive Care Med. 2018 Apr;44(4):438-448. doi: 10.1007/s00134-018-5143-7. Epub 2018 Apr 9.

38.

Potentially modifiable respiratory variables contributing to outcome in ICU patients without ARDS: a secondary analysis of PRoVENT.

Simonis FD, Barbas CSV, Artigas-Raventós A, Canet J, Determann RM, Anstey J, Hedenstierna G, Hemmes SNT, Hermans G, Hiesmayr M, Hollmann MW, Jaber S, Martin-Loeches I, Mills GH, Pearse RM, Putensen C, Schmid W, Severgnini P, Smith R, Treschan TA, Tschernko EM, Vidal Melo MF, Wrigge H, de Abreu MG, Pelosi P, Schultz MJ, Neto AS; PRoVENT investigators; PROVE Network investigators.

Ann Intensive Care. 2018 Mar 21;8(1):39. doi: 10.1186/s13613-018-0385-7.

39.

Patients with influenza A (H1N1)pdm09 admitted to the ICU. Impact of the recommendations of the SEMICYUC.

Marin-Corral J, Climent C, Muñoz R, Samper M, Dot I, Vilà C, Masclans JR, Rodriguez A, Martin-Loeches I, Álvarez-Lerma F; en representacion del Grupo de Trabajo H1N1 GETGAG SEMICYUC.

Med Intensiva. 2018 Nov;42(8):473-481. doi: 10.1016/j.medin.2018.02.002. Epub 2018 Mar 17. English, Spanish.

PMID:
29559173
40.

Community-Acquired Pneumonia: Now You See It, Now You Don't!

Rouzé A, Martin-Loeches I, Nseir S.

Chest. 2018 Mar;153(3):762-763. doi: 10.1016/j.chest.2017.08.1179. No abstract available.

PMID:
29519301
41.

Fluid therapy in neurointensive care patients: ESICM consensus and clinical practice recommendations.

Oddo M, Poole D, Helbok R, Meyfroidt G, Stocchetti N, Bouzat P, Cecconi M, Geeraerts T, Martin-Loeches I, Quintard H, Taccone FS, Geocadin RG, Hemphill C, Ichai C, Menon D, Payen JF, Perner A, Smith M, Suarez J, Videtta W, Zanier ER, Citerio G.

Intensive Care Med. 2018 Apr;44(4):449-463. doi: 10.1007/s00134-018-5086-z. Epub 2018 Mar 2. Review.

PMID:
29500701
42.

Murepavadin: a new antibiotic class in the pipeline.

Martin-Loeches I, Dale GE, Torres A.

Expert Rev Anti Infect Ther. 2018 Apr;16(4):259-268. doi: 10.1080/14787210.2018.1441024. Epub 2018 Feb 21.

PMID:
29451043
43.

Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP).

Vincent JL, Lefrant JY, Kotfis K, Nanchal R, Martin-Loeches I, Wittebole X, Sakka SG, Pickkers P, Moreno R, Sakr Y; ICON and SOAP investigators; SOAP investigators.

Intensive Care Med. 2018 Mar;44(3):337-344. doi: 10.1007/s00134-017-5043-2. Epub 2018 Feb 15.

44.

Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections.

Moreau AS, Martin-Loeches I, Povoa P, Salluh J, Rodriguez A, Thille AW, Diaz Santos E, Vedes E, Lobo SM, Mégarbane B, Molero Silvero E, Coelho L, Argaud L, Sanchez Iniesta R, Labreuche J, Rouzé A, Nseir S; TAVeM Study Group.

Eur Respir J. 2018 Mar 8;51(3). pii: 1701656. doi: 10.1183/13993003.01656-2017. Print 2018 Mar.

PMID:
29439020
45.

Relationship between acute kidney injury and serum procalcitonin (PCT) concentration in critically ill patients with influenza infection.

Rodríguez A, Reyes LF, Monclou J, Suberviola B, Bodí M, Sirgo G, Solé-Violán J, Guardiola J, Barahona D, Díaz E, Martín-Loeches I, Restrepo MI; on behalf GETGAG study group.

Med Intensiva. 2018 Oct;42(7):399-408. doi: 10.1016/j.medin.2017.12.004. Epub 2018 Feb 9. English, Spanish.

PMID:
29433841
46.

23rd International Symposium on Infections in the Critically Ill Patient.

Artigas A, Carlet J, Martin-Loeches I, Niederman M, Torres A.

Med Sci (Basel). 2018 Feb 8;6(1). pii: E13. doi: 10.3390/medsci6010013.

47.

ARDS: challenges in patient care and frontiers in research.

Bos LD, Martin-Loeches I, Schultz MJ.

Eur Respir Rev. 2018 Jan 24;27(147). pii: 170107. doi: 10.1183/16000617.0107-2017. Print 2018 Mar 31. Review.

48.

Integrative research agenda for diagnosis in sepsis.

Nolan K, O'Leary R, Bos LDJ, Martin-Loeches I.

Ann Transl Med. 2017 Nov;5(22):454. doi: 10.21037/atm.2017.06.57. No abstract available.

49.

Defects in innate and adaptive immunity in patients with sepsis and health care associated infection.

Ryan T, Coakley JD, Martin-Loeches I.

Ann Transl Med. 2017 Nov;5(22):447. doi: 10.21037/atm.2017.09.21. Review.

50.

Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Morley D, Torres A, Cillóniz C, Martin-Loeches I.

Ann Transl Med. 2017 Nov;5(22):443. doi: 10.21037/atm.2017.06.54. Review.

Supplemental Content

Loading ...
Support Center